{"prompt": "['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Property of the Sanofi Group - strictly confidential', 'Page 155', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Appendix I', 'Paediatric Rhinoconjunctivitis Quality of Life Questionnaire-', 'Interviewer Administered (PRQLQ-IA) - for Children with Comorbid', 'Allergic Rhinitis', 'The PRQLQ is copyrighted. It may not be altered, sold (paper or', 'C', 'electronic), translated or adapted for another medium without the', 'permission of Elizabeth Juniper.', 'C:\\\\My Documents\\\\WordPerfectiWpdocsiQolq\\\\NamericalPaedrhin\\\\Prina99.wpd', 'MAY 1999', 'Property of the Sanofi Group - strictly confidential', 'Page 156', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Property of the Sanofi Group - strictly confidential', 'Page 157', 'VV-CLIN-0528583 6.0']\n\n###\n\n", "completion": "END"}